| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2025―Jun―26 |
Squalene: A High-Value Compound for COVID-19 Vaccine Adjuvants and Beyond Pathways, Production Strategies, and Market Potential |
Dileep Dasari, Reeta Rani Singhania, Shashi Kant Bhatia, Cheng-Di Dong, Anil Kumar Patel |
| 2 |
[GO] |
2024―Jun―26 |
Potential COVID-19 remedies from repurposed drugs and herbal small RNAs |
Yang Yang, Fengming Huang, Xiangyu Qiao, Sheng Chen, Cong Zhang, Xingyu Deng, et al. (+7) Wentao Gu, Ling Peng, Mengli Cao, Jingmei Jiang, George F. Gao, Yingxia Liu, Chengyu Jiang |
| 3 |
[GO] |
2023―Dez―08 |
Unraveling antiviral efficacy of multifunctional immunomodulatory triterpenoids against SARS-COV-2 targeting main protease and papain-like protease |
Shweta Choudhary, Sanketkumar Nehul, Ankur Singh, Prasan Kumar Panda, Pravindra Kumar, Gaurav Kumar Sharma, Shailly Tomar |
| 4 |
[GO] |
2023―Mrz―27 |
Anti-inflammatory effects of sodium-glucose cotransporter-2 inhibitors in COVID-19 |
Habib Yaribeygi, Mina Maleki, Stephen L. Atkin, Prashant Kesharwani, Tannaz Jamialahmadi, Amirhossein Sahebkar |
| 5 |
[GO] |
2022―Nov―09 |
Involvement of sialoglycans in
SARS-COV
-2 infection: opportunities and challenges for glyco-based inhibitors |
Sakonwan Kuhaudomlarp, Anne Imberty |
| 6 |
[GO] |
2022―Apr―05 |
Herbal inhibitors of
SARS-CoV
-2 M
pro
effectively ameliorate acute lung injury in mice |
Xinyi Du, Longxin Xu, Yiming Ma, Shuaiyao Lu, Kegong Tang, Xiangyu Qiao, et al. (+4) Jiaqi Liu, Xiaona Wang, Xiaozhong Peng, Chengyu Jiang |
| 7 |
[GO] |
2021―Nov―15 |
Underlying selection for the diversity of Spike protein sequences of
SARS-CoV
-2 |
Manisha Ghosh, Surajit Basak, Shanta Dutta |
| 8 |
[GO] |
2021―Aug―21 |
2-Deoxy-D
-glucose Exploits Increased Glucose Metabolism in Cancer and Viral- infected cells: Relevance to its use in
INDIA
Against
SARS-CoV
-2 |
Enrique A. Mesri, Theodore J. Lampidis |
| 9 |
[GO] |
2021―Aug―13 |
Endoplasmic reticulum
stress and
NF-kB
activation in
SARS-CoV
-2 infected cells and their response to antiviral therapy |
Desirée Bartolini, Anna Maria Stabile, Carmine Vacca, Alessandra Pistilli, Mario Rende, Antimo Gioiello, et al. (+2) Gabriele Cruciani, Francesco Galli |
| 10 |
[GO] |
2021―Jun―12 |
The lethal internal face of the coronaviruses: Kidney tropism of the
SARS
,
MERS
, and
COVID
-19 viruses |
Roza Motavalli, Walid Kamal Abdelbasset, Heshu Sulaiman Rahman, Muhammad Harun Achmad, Angelina Olegovna Zekiy, Ali Adili, et al. (+7) Farhad Motavalli Khiavi, Faroogh Marofi, Mehdi Yousefi, Shadi Ghoreishizadeh, Navid Shomali, Jalal Etemadi, Mostafa Jarahian |
| 11 |
[GO] |
2021―Mrz―22 |
Identification of mutation resistance coldspots for targeting the
SARS-CoV2
main protease |
Navaneethakrishnan Krishnamoorthy, Khalid Fakhro |
| 12 |
[GO] |
2020―Okt―08 |
Angiotensin-converting enzyme 2: A protective factor in regulating disease virulence of SARS-COV-2 |
Vignesh Mariappan, Rao S. R., Agieshkumar Balakrishna Pillai |
| 13 |
[GO] |
2020―Sep―16 |
SARS-CoV
-2 multifaceted interaction with the human host. Part
II
: Innate immunity response, immunopathology, and epigenetics |
Tasnim H. Beacon, Ruey-Chyi Su, Ted M. Lakowski, Geneviève P. Delcuve, James R. Davie |
| 14 |
[GO] |
2020―Sep―15 |
SARS-CoV-2 multifaceted interaction with human host. Part I: What we have learnt and done so far, and the still unknown realities |
Geneviève P. Delcuve, Ted M. Lakowski, Ruey-Chyi Su, Tasnim H. Beacon, James R. Davie |
| 15 |
[GO] |
2020―Aug―28 |
Vitamin
B12
may inhibit
RNA-dependent-RNA
polymerase activity of nsp12 from the
SARS-CoV
-2 virus |
Naveen Narayanan, Deepak T. Nair |
| 16 |
[GO] |
2020―Aug―08 |
Bacterial co-infections with SARS-CoV-2 |
Rasoul Mirzaei, Pedram Goodarzi, Muhammad Asadi, Ayda Soltani, Hussain ali abraham Aljanabi, Ali Salimi Jeda, et al. (+11) Shirin Dashtbin, Saba Jalalifar, Rokhsareh Mohammadzadeh, Ali Teimoori, Kamran Tari, Mehdi Salari, Sima Ghiasvand, Sima Kazemi, Rasoul Yousefimashouf, Hossein Keyvani, Sajad Karampoor |
|
